197 filings
Page 3 of 10
8-K
CADL
Candel Therapeutics Inc
26 Sep 23
Candel Therapeutics Reports Encouraging Initial Survival Data from Phase 2 Clinical Trial of CAN-2409 in Non-Small Cell Lung Cancer
8:30am
10-Q
2023 Q2
CADL
Candel Therapeutics Inc
Quarterly report
10 Aug 23
8:31am
8-K
CADL
Candel Therapeutics Inc
10 Aug 23
Candel Therapeutics Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights
8:15am
4
Gaeta Renee
29 Jun 23
Candel Therapeutics / Renee Gaeta ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / Diem Nguyen ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / Paul B Manning ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / Christopher Martell ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / Edward J. Benz JR ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / JOSEPH C PAPA ownership change
9:00am
4
CADL
Candel Therapeutics Inc
29 Jun 23
Candel Therapeutics / Estuardo Aguilar-Cordova ownership change
9:00am
4
Gary J. Nabel
29 Jun 23
Candel Therapeutics / Gary J. Nabel ownership change
9:00am
8-K
CADL
Candel Therapeutics Inc
29 Jun 23
Submission of Matters to a Vote of Security Holders
8:31am
8-K
CADL
Candel Therapeutics Inc
13 Jun 23
Based on forthcoming completion of patient enrollment and duration of follow-up in Cohort 2 from the phase 2 trial in late-stage NSCLC
8:31am
4
Nicoletta Loggia
9 Jun 23
Candel Therapeutics / Nicoletta Loggia ownership change
8:45am
3
Nicoletta Loggia
9 Jun 23
Candel Therapeutics / Nicoletta Loggia ownership change
8:30am
8-K
CADL
Candel Therapeutics Inc
8 Jun 23
Candel Therapeutics Appoints Experienced Manufacturing Leader Nicoletta Loggia, PhD, RPh to its Board of Directors
8:15am
ARS
2022 FY
CADL
Candel Therapeutics Inc
23 May 23
Annual report to shareholders
8:01am
DEF 14A
CADL
Candel Therapeutics Inc
Definitive proxy
23 May 23
8:00am
8-K
CADL
Candel Therapeutics Inc
19 May 23
Regulation FD Disclosure
9:15am
10-Q
2023 Q1
CADL
Candel Therapeutics Inc
Quarterly report
11 May 23
8:46am